Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-03-09, Stock:ABBV, The news for the past five days is as follows:
2020-03-02: NEWS1: AbbVie Stock Rises 3%.NEWS2: Form 8.3 - ABBVIE - AMENDMENT.NEWS3: Why You Shouldn't Bet Against AbbVie (ABBV) Stock.NEWS4: AbbVie Is A Notable Coronavirus Responder — But Is ABBV Stock A Buy?.NEWS5: AbbVie's Venclexta Combo Fails in Late-Stage Leukemia Study.NEWS6: Form 8.3 - Abbvie Plc.NEWS7: Chinese Biotech Censured for False Claim on Gilead’s Virus Drug.
2020-03-03: NEWS1: FORM 8.3 - ABBVIE PLC - AMENDMENT.NEWS2: AbbVie Stock Falls 3%.NEWS3: Form 8.3 - Abbvie Plc - Amendment.NEWS4: Dividend Aristocrats Could Be Set to Lead Markets Higher.NEWS5: AbbVie and Allergan Receive Final European Approval to Close Pending Transaction.NEWS6: FORM 8.3 - ABBVIE PLC.
2020-03-04: NEWS1: These 4 Pharma Stocks Are Outplaying 90% Of The Stock Market.NEWS2: Form 8.3 - Abbvie Plc.NEWS3: AbbVie Stock Rises 3%.
2020-03-05: NEWS1: AbbVie (ABBV) Stock Moves -1.21%: What You Should Know.NEWS2: 7 Dividend Stocks That Aren’t Overly Exposed to Coronavirus, According to One Strategist.NEWS3: Form 8.3 - ABBVIE INC.NEWS4: Form 8.3 - Abbvie Plc - Amendment.NEWS5: FORM 8.3 - ABBVIE PLC - AMENDMENT.
2020-03-06: NEWS1: 12 Dividend Stocks to Buy Amid Turmoil in the Markets.NEWS2: Pfizer Won’t Win the Coronavirus Pharma War.NEWS3: Allergan's (AGN) Glaucoma Implant Durysta Gets FDA Approval.NEWS4: Form 8.3 - ABBVIE INC AMENDMENT.NEWS5: Pharma Stock Roundup: Trump, Pharma Executives Meeting on Coronavirus, FDA Updates.NEWS6: Simple Secrets Anyone Can Use to Reach Early Retirement - March 06, 2020.NEWS7: The Daily Biotech Pulse: Breakthrough Device Designation For Neuronetics, AbbVie Receives European Label Expansion, AstraZeneca Flunks Late-Stage Study.NEWS8: FORM 8.3 - ABBVIE PLC.NEWS9: European Commission Grants AbbVie Marketing Authorization Shortening MAVIRET® (glecaprevir/pibrentasvir) Treatment Duration to Eight Weeks for Treatment-Naïve Chronic HCV Patients with Genotype 3 and Compensated Cirrhosis.NEWS10: AbbVie Stock Falls 3%.

Answer: Decrease